nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclopentolate—BCHE—Neurotransmitter Clearance In The Synaptic Cleft—SLC6A3—attention deficit hyperactivity disorder	0.0391	0.0447	CbGpPWpGaD
Cyclopentolate—BCHE—Neurotransmitter Clearance In The Synaptic Cleft—COMT—attention deficit hyperactivity disorder	0.0333	0.038	CbGpPWpGaD
Cyclopentolate—BCHE—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—attention deficit hyperactivity disorder	0.033	0.0378	CbGpPWpGaD
Cyclopentolate—CHRM1—Monoamine GPCRs—ADRA2C—attention deficit hyperactivity disorder	0.0198	0.0226	CbGpPWpGaD
Cyclopentolate—CHRM3—Monoamine GPCRs—ADRA2C—attention deficit hyperactivity disorder	0.0197	0.0225	CbGpPWpGaD
Cyclopentolate—CHRM1—Monoamine GPCRs—DRD5—attention deficit hyperactivity disorder	0.0194	0.0221	CbGpPWpGaD
Cyclopentolate—CHRM3—Monoamine GPCRs—DRD5—attention deficit hyperactivity disorder	0.0193	0.0221	CbGpPWpGaD
Cyclopentolate—CHRM1—Amine ligand-binding receptors—ADRA2C—attention deficit hyperactivity disorder	0.0166	0.019	CbGpPWpGaD
Cyclopentolate—CHRM3—Amine ligand-binding receptors—ADRA2C—attention deficit hyperactivity disorder	0.0166	0.0189	CbGpPWpGaD
Cyclopentolate—CHRM1—Amine ligand-binding receptors—DRD5—attention deficit hyperactivity disorder	0.0163	0.0186	CbGpPWpGaD
Cyclopentolate—CHRM3—Amine ligand-binding receptors—DRD5—attention deficit hyperactivity disorder	0.0162	0.0185	CbGpPWpGaD
Cyclopentolate—Desvenlafaxine—SLC6A4—attention deficit hyperactivity disorder	0.0149	0.193	CrCbGaD
Cyclopentolate—CHRM1—Monoamine GPCRs—HTR1B—attention deficit hyperactivity disorder	0.0117	0.0134	CbGpPWpGaD
Cyclopentolate—CHRM3—Monoamine GPCRs—HTR1B—attention deficit hyperactivity disorder	0.0117	0.0134	CbGpPWpGaD
Cyclopentolate—CHRM1—Amine ligand-binding receptors—HRH3—attention deficit hyperactivity disorder	0.0113	0.0129	CbGpPWpGaD
Cyclopentolate—CHRM3—Amine ligand-binding receptors—HRH3—attention deficit hyperactivity disorder	0.0112	0.0128	CbGpPWpGaD
Cyclopentolate—CHRM1—Monoamine GPCRs—DRD1—attention deficit hyperactivity disorder	0.0109	0.0125	CbGpPWpGaD
Cyclopentolate—CHRM3—Monoamine GPCRs—DRD1—attention deficit hyperactivity disorder	0.0109	0.0124	CbGpPWpGaD
Cyclopentolate—CHRM1—Monoamine GPCRs—DRD3—attention deficit hyperactivity disorder	0.0106	0.0121	CbGpPWpGaD
Cyclopentolate—CHRM3—Monoamine GPCRs—DRD3—attention deficit hyperactivity disorder	0.0105	0.012	CbGpPWpGaD
Cyclopentolate—CHRM1—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.0104	0.0119	CbGpPWpGaD
Cyclopentolate—CHRM3—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.0103	0.0118	CbGpPWpGaD
Cyclopentolate—CHRM1—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.0103	0.0117	CbGpPWpGaD
Cyclopentolate—CHRM3—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.0102	0.0117	CbGpPWpGaD
Cyclopentolate—Methylphenidate—SLC6A3—attention deficit hyperactivity disorder	0.0102	0.132	CrCbGaD
Cyclopentolate—Dexmethylphenidate—SLC6A3—attention deficit hyperactivity disorder	0.0102	0.132	CrCbGaD
Cyclopentolate—Venlafaxine—SLC6A3—attention deficit hyperactivity disorder	0.01	0.131	CrCbGaD
Cyclopentolate—CHRM3—Regulation of insulin secretion—ADRA2C—attention deficit hyperactivity disorder	0.01	0.0114	CbGpPWpGaD
Cyclopentolate—CHRM1—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.00986	0.0113	CbGpPWpGaD
Cyclopentolate—CHRM3—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.00983	0.0112	CbGpPWpGaD
Cyclopentolate—CHRM1—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.00955	0.0109	CbGpPWpGaD
Cyclopentolate—CHRM3—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.00952	0.0109	CbGpPWpGaD
Cyclopentolate—CHRM1—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.00916	0.0105	CbGpPWpGaD
Cyclopentolate—CHRM3—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.00914	0.0104	CbGpPWpGaD
Cyclopentolate—CHRM1—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.00888	0.0101	CbGpPWpGaD
Cyclopentolate—CHRM3—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.00885	0.0101	CbGpPWpGaD
Cyclopentolate—CHRM1—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.00872	0.00997	CbGpPWpGaD
Cyclopentolate—CHRM3—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.0087	0.00994	CbGpPWpGaD
Cyclopentolate—CHRM1—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.00862	0.00985	CbGpPWpGaD
Cyclopentolate—CHRM3—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.00859	0.00982	CbGpPWpGaD
Cyclopentolate—BCHE—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00817	0.00934	CbGpPWpGaD
Cyclopentolate—CHRM1—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.00803	0.00917	CbGpPWpGaD
Cyclopentolate—CHRM3—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.008	0.00914	CbGpPWpGaD
Cyclopentolate—CHRM3—Integration of energy metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00786	0.00898	CbGpPWpGaD
Cyclopentolate—Dexmethylphenidate—SLC6A4—attention deficit hyperactivity disorder	0.0076	0.0988	CrCbGaD
Cyclopentolate—Methylphenidate—SLC6A4—attention deficit hyperactivity disorder	0.0076	0.0988	CrCbGaD
Cyclopentolate—Venlafaxine—SLC6A4—attention deficit hyperactivity disorder	0.00751	0.0976	CrCbGaD
Cyclopentolate—CHRM3—Regulation of insulin secretion—CACNB2—attention deficit hyperactivity disorder	0.0069	0.00789	CbGpPWpGaD
Cyclopentolate—CHRM1—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.00669	0.00764	CbGpPWpGaD
Cyclopentolate—CHRM3—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.00667	0.00762	CbGpPWpGaD
Cyclopentolate—CHRM3—Regulation of insulin secretion—CACNA1C—attention deficit hyperactivity disorder	0.00631	0.00721	CbGpPWpGaD
Cyclopentolate—BCHE—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00626	0.00715	CbGpPWpGaD
Cyclopentolate—CHRM1—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.00562	0.00642	CbGpPWpGaD
Cyclopentolate—CHRM3—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.0056	0.0064	CbGpPWpGaD
Cyclopentolate—CHRM3—Regulation of insulin secretion—SNAP25—attention deficit hyperactivity disorder	0.00552	0.00631	CbGpPWpGaD
Cyclopentolate—CHRM1—forebrain—attention deficit hyperactivity disorder	0.00543	0.113	CbGeAlD
Cyclopentolate—CHRM3—Integration of energy metabolism—CACNB2—attention deficit hyperactivity disorder	0.00543	0.0062	CbGpPWpGaD
Cyclopentolate—CHRM3—Regulation of insulin secretion—ADRA2A—attention deficit hyperactivity disorder	0.00525	0.006	CbGpPWpGaD
Cyclopentolate—Pethidine—SLC6A3—attention deficit hyperactivity disorder	0.00514	0.0668	CrCbGaD
Cyclopentolate—CHRM3—Integration of energy metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00496	0.00567	CbGpPWpGaD
Cyclopentolate—CHRM3—forebrain—attention deficit hyperactivity disorder	0.00486	0.101	CbGeAlD
Cyclopentolate—CHRM3—GPCRs, Other—DRD3—attention deficit hyperactivity disorder	0.00468	0.00534	CbGpPWpGaD
Cyclopentolate—CHRM1—cardiovascular system—attention deficit hyperactivity disorder	0.00459	0.0958	CbGeAlD
Cyclopentolate—CHRM3—GPCRs, Other—DRD4—attention deficit hyperactivity disorder	0.00454	0.00519	CbGpPWpGaD
Cyclopentolate—CHRM3—Integration of energy metabolism—SNAP25—attention deficit hyperactivity disorder	0.00434	0.00496	CbGpPWpGaD
Cyclopentolate—BCHE—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00418	0.00478	CbGpPWpGaD
Cyclopentolate—CHRM3—Integration of energy metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00413	0.00472	CbGpPWpGaD
Cyclopentolate—BCHE—forebrain—attention deficit hyperactivity disorder	0.00397	0.0827	CbGeAlD
Cyclopentolate—Pethidine—SLC6A4—attention deficit hyperactivity disorder	0.00385	0.05	CrCbGaD
Cyclopentolate—CHRM1—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00381	0.00436	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.0038	0.00434	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00374	0.00427	CbGpPWpGaD
Cyclopentolate—CHRM1—Calcium Regulation in the Cardiac Cell—CACNA1C—attention deficit hyperactivity disorder	0.00373	0.00427	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00372	0.00426	CbGpPWpGaD
Cyclopentolate—CHRM3—Calcium Regulation in the Cardiac Cell—CACNA1C—attention deficit hyperactivity disorder	0.00372	0.00425	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00371	0.00424	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.0037	0.00423	CbGpPWpGaD
Cyclopentolate—BCHE—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.0036	0.00411	CbGpPWpGaD
Cyclopentolate—BCHE—cardiovascular system—attention deficit hyperactivity disorder	0.00335	0.0699	CbGeAlD
Cyclopentolate—BCHE—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00334	0.00382	CbGpPWpGaD
Cyclopentolate—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00327	0.00373	CbGpPWpGaD
Cyclopentolate—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00326	0.00372	CbGpPWpGaD
Cyclopentolate—CHRM1—Circadian rythm related genes—TPH2—attention deficit hyperactivity disorder	0.00321	0.00367	CbGpPWpGaD
Cyclopentolate—BCHE—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.0032	0.00366	CbGpPWpGaD
Cyclopentolate—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.0032	0.00366	CbGpPWpGaD
Cyclopentolate—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00319	0.00365	CbGpPWpGaD
Cyclopentolate—BCHE—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00298	0.00341	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCRs, Other—HTR2A—attention deficit hyperactivity disorder	0.00296	0.00338	CbGpPWpGaD
Cyclopentolate—CHRM1—nervous system—attention deficit hyperactivity disorder	0.00295	0.0615	CbGeAlD
Cyclopentolate—CHRM1—central nervous system—attention deficit hyperactivity disorder	0.00284	0.0592	CbGeAlD
Cyclopentolate—BCHE—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00276	0.00315	CbGpPWpGaD
Cyclopentolate—CHRM3—nervous system—attention deficit hyperactivity disorder	0.00264	0.055	CbGeAlD
Cyclopentolate—BCHE—midbrain—attention deficit hyperactivity disorder	0.00262	0.0546	CbGeAlD
Cyclopentolate—CHRM1—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00259	0.00296	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00258	0.00295	CbGpPWpGaD
Cyclopentolate—CHRM1—Circadian rythm related genes—SLC6A4—attention deficit hyperactivity disorder	0.00257	0.00294	CbGpPWpGaD
Cyclopentolate—CHRM1—Circadian rythm related genes—DRD1—attention deficit hyperactivity disorder	0.00257	0.00294	CbGpPWpGaD
Cyclopentolate—BCHE—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00256	0.00293	CbGpPWpGaD
Cyclopentolate—CHRM3—central nervous system—attention deficit hyperactivity disorder	0.00254	0.053	CbGeAlD
Cyclopentolate—BCHE—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.00253	0.0029	CbGpPWpGaD
Cyclopentolate—BCHE—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.00252	0.00288	CbGpPWpGaD
Cyclopentolate—CHRM1—Circadian rythm related genes—DRD3—attention deficit hyperactivity disorder	0.00249	0.00284	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00249	0.00284	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00248	0.00283	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00244	0.00279	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00243	0.00278	CbGpPWpGaD
Cyclopentolate—CHRM1—Circadian rythm related genes—DRD4—attention deficit hyperactivity disorder	0.00242	0.00276	CbGpPWpGaD
Cyclopentolate—BCHE—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.00228	0.00261	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00226	0.00259	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00226	0.00258	CbGpPWpGaD
Cyclopentolate—CHRM1—brain—attention deficit hyperactivity disorder	0.00225	0.047	CbGeAlD
Cyclopentolate—CHRM1—Circadian rythm related genes—DRD2—attention deficit hyperactivity disorder	0.00225	0.00257	CbGpPWpGaD
Cyclopentolate—CHRM1—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00222	0.00254	CbGpPWpGaD
Cyclopentolate—CHRM3—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00221	0.00253	CbGpPWpGaD
Cyclopentolate—BCHE—nervous system—attention deficit hyperactivity disorder	0.00215	0.0449	CbGeAlD
Cyclopentolate—CHRM1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.0021	0.0024	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.0021	0.0024	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.0021	0.0024	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00209	0.00239	CbGpPWpGaD
Cyclopentolate—BCHE—central nervous system—attention deficit hyperactivity disorder	0.00207	0.0432	CbGeAlD
Cyclopentolate—CHRM1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00204	0.00233	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00203	0.00232	CbGpPWpGaD
Cyclopentolate—BCHE—cerebellum—attention deficit hyperactivity disorder	0.00203	0.0423	CbGeAlD
Cyclopentolate—CHRM3—brain—attention deficit hyperactivity disorder	0.00202	0.0421	CbGeAlD
Cyclopentolate—CHRM1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.002	0.00229	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.002	0.00228	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00198	0.00226	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00197	0.00225	CbGpPWpGaD
Cyclopentolate—BCHE—Neuronal System—COMT—attention deficit hyperactivity disorder	0.00194	0.00222	CbGpPWpGaD
Cyclopentolate—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00194	0.00222	CbGpPWpGaD
Cyclopentolate—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00193	0.00221	CbGpPWpGaD
Cyclopentolate—BCHE—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.00193	0.0022	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.0019	0.00218	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.0019	0.00217	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00184	0.00211	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00184	0.0021	CbGpPWpGaD
Cyclopentolate—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.0018	0.00206	CbGpPWpGaD
Cyclopentolate—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.0018	0.00205	CbGpPWpGaD
Cyclopentolate—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00175	0.002	CbGpPWpGaD
Cyclopentolate—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00174	0.00199	CbGpPWpGaD
Cyclopentolate—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00172	0.00196	CbGpPWpGaD
Cyclopentolate—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00171	0.00195	CbGpPWpGaD
Cyclopentolate—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00169	0.00194	CbGpPWpGaD
Cyclopentolate—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00169	0.00193	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00169	0.00193	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00168	0.00192	CbGpPWpGaD
Cyclopentolate—CHRM1—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.00167	0.00191	CbGpPWpGaD
Cyclopentolate—CHRM3—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.00166	0.0019	CbGpPWpGaD
Cyclopentolate—BCHE—brain—attention deficit hyperactivity disorder	0.00165	0.0343	CbGeAlD
Cyclopentolate—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00158	0.0018	CbGpPWpGaD
Cyclopentolate—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00157	0.0018	CbGpPWpGaD
Cyclopentolate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.00149	0.00171	CbGpPWpGaD
Cyclopentolate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.00149	0.0017	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00148	0.00169	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00147	0.00168	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00141	0.00161	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.0014	0.0016	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00138	0.00157	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00137	0.00157	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00137	0.00157	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00137	0.00156	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00133	0.00152	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00133	0.00151	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00131	0.00149	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.0013	0.00149	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00129	0.00147	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00129	0.00147	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00129	0.00147	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00129	0.00147	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00128	0.00146	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00127	0.00145	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00125	0.00143	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00125	0.00142	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.0012	0.00137	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.0012	0.00137	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00117	0.00134	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00112	0.00128	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00112	0.00128	CbGpPWpGaD
Cyclopentolate—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00111	0.00126	CbGpPWpGaD
Cyclopentolate—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.0011	0.00126	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000955	0.00109	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000952	0.00109	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000899	0.00103	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000878	0.001	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000875	0.001	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000867	0.000991	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000864	0.000988	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000842	0.000962	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000839	0.000959	CbGpPWpGaD
Cyclopentolate—CHRM1—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	0.000835	0.000954	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000834	0.000954	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000832	0.000951	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000807	0.000922	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000807	0.000922	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000794	0.000907	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000776	0.000887	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000773	0.000884	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000758	0.000866	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000755	0.000863	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000754	0.000862	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000752	0.000859	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000751	0.000859	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000749	0.000856	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000739	0.000844	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000739	0.000844	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000738	0.000843	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000737	0.000842	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000736	0.000841	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000729	0.000833	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000727	0.000831	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000725	0.000828	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000722	0.000825	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000704	0.000805	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000702	0.000802	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000682	0.00078	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00068	0.000777	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000679	0.000776	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000677	0.000774	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000671	0.000766	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000669	0.000764	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000662	0.000757	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00066	0.000754	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000645	0.000737	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000621	0.000709	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000621	0.000709	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000617	0.000705	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000615	0.000703	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000614	0.000702	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000611	0.000698	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000568	0.000649	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000512	0.000585	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000511	0.000583	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000496	0.000567	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—COMT—attention deficit hyperactivity disorder	0.000489	0.000559	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000485	0.000555	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000476	0.000544	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000474	0.000542	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000472	0.00054	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000471	0.000538	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000448	0.000512	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000446	0.00051	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000432	0.000494	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000431	0.000492	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000416	0.000476	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000415	0.000474	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000403	0.000461	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000402	0.000459	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000396	0.000453	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000395	0.000451	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000391	0.000447	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.00039	0.000446	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—COMT—attention deficit hyperactivity disorder	0.000376	0.00043	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000373	0.000427	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000364	0.000417	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000363	0.000415	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000255	0.000292	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000254	0.000291	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—EP300—attention deficit hyperactivity disorder	0.00021	0.00024	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—EP300—attention deficit hyperactivity disorder	0.000161	0.000184	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000135	0.000155	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000135	0.000154	CbGpPWpGaD
